Showing results (291-300 of 569) with videos related to
Sort By:
Pageof 57
Clinical and Experimental Pharmacology & Physiology|September 1, 1980
Assessment of neuronal uptake of noradrenaline in humans: defective uptake in some patients with essential hypertensionM Esler, P Leonard, D Kelleher, et al.American Journal of Hematology|September 5, 2009
Repeated courses of rituximab in chronic ITP: Three different regimensAisha Hasan, Marc Michel, Vivek Patel, et al.Journal of Health Communication|April 15, 2010
Individuals' willingness to talk to their doctors about clinical trial enrollmentKatherine A McComas, Zheng Yang, Geri K Gay, et al.Trends in Microbiology|June 9, 2021
Engineering insects from the endosymbiont outKatherine M Elston, Sean P Leonard, Peng Geng, et al.Journal of Cancer Survivorship : Research and Practice|March 4, 2021
Racial disparities in diabetes care among incident breast, prostate, and colorectal cancer survivors: a SEER Medicare studyLaura C Pinheiro, Orysya Soroka, Lisa M Kern, et al.Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 15, 2024
Nodal T-Cell Lymphoma Transdifferentiated from Mantle Cell Lymphoma with Epstein-Barr Virus InfectionPaul D Barone, Wayne Tam, Julia T Geyer, et al.The Journal of Urology|August 21, 2007
Development of an objective score to quantify the pediatric cystometrogramA L MacNeily, M P Leonard, P D Metcalfe, et al.Journal of the American Medical Informatics Association : JAMIA|December 1, 2021
An architecture for research computing in health to support clinical and translational investigators with electronic patient dataThomas R Campion, Evan T Sholle, Jyotishman Pathak, et al.Clinical Advances in Hematology & Oncology : H&O|June 24, 2008
Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphomaJohn P Leonard, Stephanie A Gregory, David G Maloney, et al.Journal of Medicinal Chemistry|September 1, 1989
Introduction of a putative dopaminergic prodrug moiety into a 6,7-substitution pattern characteristic of certain 2-aminotetralin dopaminergic agonistsJ G Cannon, C D True, J P Long, et al.Pageof 57